AI identified 23 potential antibiotic peptides within prion proteins
Prionins could bypass existing bacterial resistance mechanisms
Human trials may begin within 3-5 years
This approach repurposes harmful proteins for medical benefit
Prionins showed 3x greater potency against drug-resistant E. coli than conventional antibiotics in lab tests.